在器官移植领域应用基因治疗具有很大的优越性。将能调控移植排斥反应的蛋白质分子的编码基因导入移植物 ,可以在移植物局部持续产生这些调控分子 ,与全身应用半衰期很短的免疫抑制剂相比 ,既可维持局部的免疫抑制或诱导免疫耐受 ,又可减少或避免对全身的副作用。现将在同种异 The application of gene therapy in the field of organ transplantation has great advantages. The introduction of the gene encoding a protein molecule that regulates transplant rejection into the graft allows for the continued production of these regulatory molecules locally in the graft and maintains either local immunosuppression or induction of immunity compared to systemic application of immunosuppressive agents with short half-lives Tolerance, but also reduce or avoid the side effects of the whole body. Will be the same